RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the ...

Deutsche Bank raised the firm’s price target on CVS Health (CVS) to $70 from $66 and keeps a Buy rating on the shares. The company issued a ...

CVS Health has eliminated more than 1,000 jobs based at or reporting to its offices in Hartford, which include the ...

The positive investor sentiment on CVS is due to the pharmacy chain operator's fourth-quarter earnings report, which were published early Wednesday morning. The company squeaked past the consensus ...

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

Shares of CVS Health Corporation (NYSE: CVS) experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's ...

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high.

CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — ...

CVS Health plans to shed enrollment by more than 1 million members this year, mostly in Medicare Advantage and individual ...

CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that largely met ...

Explore the latest updates from Wall Street as U.S. stocks slip due to rising inflation rates affecting consumers' costs.